TY  - JOUR
AU  - Rubio-Salvador, Ana Rosa
AU  - Escudero-Vilaplana, Vicente
AU  - Marcos Rodríguez, José Antonio
AU  - Mangues-Bafalluy, Irene
AU  - Bernárdez, Beatriz
AU  - García Collado, Carlos
AU  - Collado-Borrell, Roberto
AU  - Alvarado Fernández, María Dolores
AU  - Chacón López-Muñiz, José Ignacio
AU  - Yébenes Cortés, María
AU  - Gómez Barrera, Manuel
AU  - Calleja-Hernández, Miguel Ángel
PY  - 2021
DO  - 10.3390/ijerph18020394
UR  - http://hdl.handle.net/10668/16941
T2  - International journal of environmental research and public health
AB  - Patients with lung cancer (LC) are at significantly higher risk of developing venous thromboembolism (VTE), which may lead to increased use of health resources and the cost of management. The main aim of the study was to determine the cost of the...
LA  - en
KW  - LMWH
KW  - cancer
KW  - cost
KW  - economic impact
KW  - thromboembolic disease
KW  - Anticoagulants
KW  - Female
KW  - Heparin, Low-Molecular-Weight
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Spain
KW  - Venous Thrombosis
TI  - Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: Costecat Study.
TY  - research article
VL  - 18
ER  -